In JMP Clinical 8, we already have templates about efficacy for oncology studies.
Some clients are curious about if there would be more efficacy templates(for other therapy areas) adding to our JMP Clinical and their questions provoke my thoughts.
In my view, it means various efficacy analyses for different therapy areas should be standardized like those safety analyses. But can efficacy analysis (templates/reports) really be standardized? For example, in Atopic Dermatitis studies, many endpoints like EASI/IGA/PtGA/DLQI... will be used and the statistical methods vary in different studies.
I would like to hear your guys' ideas about this topic.:smiling_face_with_smiling_eyes: